Benzinga | Nov 22, 2021 07:14AM EST

Mizuho Maintains Neutral on Amgen, Lowers Price Target to $194

Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and lowers the price target from $222 to $194.